Translational Immunology Fellow – Type 1 Diabetes

Massachusetts General Physicians Organization, Inc.; Boston (MA); On-site; USD 70,000 - 72,000; Full time

Job summary

The Vaccine and Immunotherapy Center at Massachusetts General Hospital offers a two-year private foundation postdoctoral fellowship focused on translational medical research for type I diabetes. The fellow will study gene- and cell-therapy approaches and will work with multidisciplinary teams across immunology, transplantation, and data analysis.

Responsibilities include hands-on experimental work, collaboration with external partners, and advancing preclinical work toward clinical stages.

Qualifications

• PhD in Biology, Immunology, Biochemistry, or related field.
• Strong publication record and ability to write funding proposals.
• Understanding/knowledge of gene delivery systems, transplant tolerance and transplant biology.
• Passionate and curious to advance therapies from preclinical to clinical stage.
• Strong interpersonal, organizational and communication skills.

Responsibilities

• Conduct experiments and analyze data in immunomodulatory and cell-gene therapies for type I diabetes.
• Collaborate with outside academic and industry partners.
• Design novel translational studies using mouse models of disease.

Skills

Strong publication record

Interpersonal skills

Data analysis

Experimental design

Communication skills

Education

PhD in Biology/Immunology/Biochemistry or related field

Tools

qPCR

Western blot

ELISPOT

Flow cytometry

Non-viral gene delivery

AAV-based approaches

Job description

The Vaccine and Immunotherapy Center at Massachusetts General Hospital offers a two-year private foundation postdoctoral fellowship focused on translational medical research for type I diabetes. The fellow will study gene- and cell-therapy approaches and will work with multidisciplinary teams across immunology, transplantation, and data analysis.

Responsibilities include hands-on experimental work, collaboration with external partners, and advancing preclinical work toward clinical stages.